The United States Patent and Trademark Office (USPTO) has published a trademark application for the mark 'MELIOONE' (Application No. TM79434759). The application, filed on September 18, 2025, seeks to register the mark for goods including pain relief medication, pain relief preparations, intrauterine devices, applicators for pharmaceutical preparations, and medical devices for introducing pharmaceutical preparations into the human body.

This publication signifies that the application has passed initial examination and is now open for opposition by third parties for a period. Companies operating in the pharmaceutical and medical device sectors should monitor this application if the mark or its associated goods/services could conflict with their own branding or product lines. No immediate compliance actions are required for entities not involved in opposing the trademark.